Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control,Expert Review of Pharmacoeconomics & Outcomes Research

当前位置： X-MOL 学术 › Expert Rev. Pharmacoecon. Outcomes Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2024-04-08 , DOI: 10.1080/14737167.2024.2333337
Janice Seinfeld ₁ , Alfredo Sobrevilla ₁ , María Laura Rosales ₁ , Mauricio Ibáñez ₁ , Delia Ruiz ₁ , Eduardo Penny ₁ , Sergio Londoño ₂

Affiliation

Type 2 diabetes mellitus (T2DM) represents an increasing public health problem in Peru. This study aims to estimate the national economic burden of this disease for the public funder, the social se...

中文翻译：